- Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
-
Li Y, Ali S, Clarke J, Cha S
- KMID: 2378298
- Brain Tumor Res Treat.
- 2017 Apr;5(1):1-9.
- doi: 10.14791/btrt.2017.5.1.1
Glioblastoma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody against the vascular endothelial growth factor receptor,... -
- CITED
-
- Close
- SHARE
-
- Close
